On the evening of July 12, Zhejiang Orient Gene Biotech Co., Ltd announced that its wholly owned subsidiary, Shanghai Wanzi Health Medical Laboratory Co., Ltd., had obtained medical device registration certificates for carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragment detection kit (flow fluorescence luminescence method).

Researchers have used laboratory-on-a-chip technology to create a low cost, sensitive tuberculosis (TB) test that could improve disease detection in high-endemic, under-resourced areas.

TinkerBio completed a Series A+ financing round of tens of millions of RMB, exclusively invested by Panlin Capital.

ALiA BioTech group has announced the deployment of its Lab-on-Chip diagnostic platform, which can perform multiplex testing using a single biochip.